# Biocon Biologics Limited - Inspection Records Source: https://www.keypedia.com/companies/biocon-biologics-limited/7eb84509-8dc4-4765-9a0e-d2f65781328d > Inspection records and compliance data for Biocon Biologics Limited in Bengaluru, None. Access full analysis and detailed observations. --- ## Details - Name: Biocon Biologics Limited - FEI Number: 3003981475 - City: Bengaluru - State: None - Country Name: India - Address Line 1: Block No, B1,B2, B3, B5, Q13 Of Q1 And W20 & Unit S18,1st Floor, Block B4, Sez, Plot No.2,3,4&5, Phase Iv, Bommasandra-Jigani Link Road - Zip Code: None - Facility Type: Drug Substance & Drug Product Manufacturer - Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK ## Related Documents - [483 - Biocon Biologics Limited - Unknown Date](https://www.keypedia.com/records/483/biocon-biologics-limited/1dff6c9a-dd43-4ecd-bfcd-53b9e68b1d05) — source: FDA, date: Invalid Date - [483 - Biocon Biologics Limited - Unknown Date](https://www.keypedia.com/records/483/biocon-biologics-limited/fdee272a-ef56-45fc-8061-233169edfabf) — source: FDA, date: Invalid Date - [483 - Biocon Biologics Limited - Unknown Date](https://www.keypedia.com/records/483/biocon-biologics-limited/34a3f80d-5688-4e63-9006-3751d02f3b25) — source: FDA, date: Invalid Date - [483 - Biocon Biologics Limited - 2024-07-26](https://www.keypedia.com/records/483/biocon-biologics-limited/edb15a2b-be4c-4cce-a170-6454059f2901) — source: FDA, date: July 26, 2024 - [483 - Biocon Biologics Limited - 2024-07-26](https://www.keypedia.com/records/483/biocon-biologics-limited/05a654d1-f83f-49b1-80a9-56f70dca615f) — source: FDA, date: July 26, 2024 - [FDA Inspection 1245708 - Biocon Biologics Limited - 2024-07-26](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/687d3404-f2a1-4dc0-bfbb-745764ac52d8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2024 - [483 - Biocon Biologics Limited - 2022-08-26](https://www.keypedia.com/records/483/biocon-biologics-limited/389806fd-0ee4-4841-b19c-fe0c775d7c7b) — source: FDA, date: August 26, 2022 - [483 - Biocon Biologics Limited - 2022-08-26](https://www.keypedia.com/records/483/biocon-biologics-limited/6d696c01-1fee-4b41-9f1e-ae5c564a08fa) — source: FDA, date: August 26, 2022 - [483 - Biocon Biologics Limited - 2022-08-19](https://www.keypedia.com/records/483/biocon-biologics-limited/152eb2db-adeb-44c2-883a-bdac69a6cc99) — source: FDA, date: August 19, 2022 - [483 - Biocon Biologics Limited - 2019-09-19](https://www.keypedia.com/records/483/biocon-biologics-limited/81b17a36-3d2a-4a82-a70c-77f6fce4507a) — source: FDA, date: September 19, 2019 - [FDA Inspection 1100840 - Biocon Biologics Limited - 2019-08-30](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/bda77216-5fdd-4704-b7c9-90ceecdde4ef) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2019 - [483 - Biocon Biologics Limited - 2019-02-15](https://www.keypedia.com/records/483/biocon-biologics-limited/3858f9b9-9837-4adb-9001-eeb4c7a62761) — source: FDA, date: February 15, 2019 - [FDA Inspection 1050980 - Biocon Biologics Limited - 2018-05-01](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/7991b681-ff48-4be4-b758-595d97e70837) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 1, 2018 - [FDA Inspection 1016114 - Biocon Biologics Limited - 2017-06-03](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/7328e444-a60d-4390-b252-256bf9a29dfd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 3, 2017 - [FDA Inspection 948968 - Biocon Biologics Limited - 2015-10-29](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/92298ebd-8a54-4a80-b128-b2fb9600f04a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 29, 2015 - [FDA Inspection 934266 - Biocon Biologics Limited - 2015-06-16](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/c1f2aae7-0bfb-472b-8e5c-6db5f4b991e8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 16, 2015 - [FDA Inspection 793259 - Biocon Biologics Limited - 2012-06-19](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/9ed98396-a244-4332-8c0f-c1b60197af63) — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2012 - [FDA Inspection 790624 - Biocon Biologics Limited - 2012-06-13](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/c0aaaa2f-b9dd-40db-a287-715ce2ae717f) — classification: No Action Indicated (NAI), source: FDA, date: June 13, 2012 - [FDA Inspection 560965 - Biocon Biologics Limited - 2009-01-29](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/fa65562b-baef-4889-bd71-fad0982c1dcc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2009 - [FDA Inspection 584568 - Biocon Biologics Limited - 2009-01-29](https://www.keypedia.com/records/fda_inspections/biocon-biologics-limited/9fb37f43-dc0d-4a0c-9005-4f96d55a7f82) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2009 ## Related Companies - [Eugia SEZ Private Limited](https://www.keypedia.com/companies/eugia-sez-private-limited/c458dd25-5620-40af-93fe-f25936ff47e8) - [RK Pharma Inc.](https://www.keypedia.com/companies/rk-pharma-inc/04d6c855-6dac-45ed-8597-0541bddd3bce) - [Shilpa Medicare Limited](https://www.keypedia.com/companies/shilpa-medicare-limited/9184777f-89bb-4a33-bcb2-4cc2aa4eb655) - [Intas Pharmaceuticals Limited](https://www.keypedia.com/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8) - [Dr. Reddy’s Laboratories Limited](https://www.keypedia.com/companies/dr-reddys-laboratories-limited/19f1fec5-d1fb-47f3-92bb-7e3e0f0db5d6) - [Eugia Steriles Private Limited](https://www.keypedia.com/companies/eugia-steriles-private-limited/99c18f9f-25c2-4d7b-baf2-fbbbf464ef64) - [Eugia Pharma Specialities Limited](https://www.keypedia.com/companies/eugia-pharma-specialities-limited/9733456f-3189-4fe6-a4f9-327f0ce92559) - [Catalent Massachusetts, LLC](https://www.keypedia.com/companies/catalent-massachusetts-llc/26c89be4-8caa-4cb8-a699-31729cda5497) - [EUGIA Pharma Specialities Limited](https://www.keypedia.com/companies/eugia-pharma-specialities-limited/7c9f680c-5d29-42a0-a496-02fd4761792b) - [Catalent Maryland, Inc.](https://www.keypedia.com/companies/catalent-maryland-inc/b2f722ce-b6bd-42e6-b648-cec5c4b5f44d) ## Related Officers - [Legal Representative/ General Manager](https://www.keypedia.com/people/zheng-liang/1ec6da08-bee5-4fa0-bca4-342c3a8c7f9b) - [Ralph M. Bernstein](https://www.keypedia.com/people/ralph-m-bernstein/72173dfb-24ae-42a1-af9e-1dc7da02ed87) - [investigator](https://www.keypedia.com/people/laura-fontan/b27b02a3-9ab1-49df-b2bc-ee936b69d76a) - [Laurie A. Nelson](https://www.keypedia.com/people/laurie-a-nelson/dbd373d1-ce1f-486c-a932-d93f8f52832d) - [Ganesh D. Reddy](https://www.keypedia.com/people/ganesh-d-reddy/c5553672-1f1e-431c-be37-4862a203c27d)